Josh Tolkoff

Josh Tolkoff is an Accelerator Executive at the Consortium for Integrating Medical Innovation & Technology (CIMIT), where he focuses on accelerating the commercialization of research projects in the healthcare sector. He has a robust background in venture investment and medical device development.

Professional Background

• Previous Roles: Tolkoff was the Managing Director of Ironwood Equity Fund, a late-stage venture investor. He also founded and managed Seedling Enterprises, recognized as a successful medical device accelerator, and ACT Medical, a prominent medical device developer and manufacturer. Earlier in his career, he served as the Head of R&D for Medi-Tech, which later became part of Boston Scientific.
• Industry Contributions: He has held leadership positions in various organizations, including serving as the Past Chair of MassMedic, an industry trade group. Additionally, he is involved as an advisor and lecturer for the Harvard-MIT program in Health Sciences and Technology.
• Board Memberships: Tolkoff is a director for multiple for-profit companies and is the founding Board Chair of Interise, a non-profit aimed at helping small urban businesses grow across over 75 U.S. cities.

Education

Josh Tolkoff holds an AB from Harvard College and an MS from MIT, reflecting his strong academic foundation in both liberal arts and science/technology disciplines.

Current Role

At CIMIT, Tolkoff plays a crucial role in bridging the gap between innovative research and practical application in healthcare, emphasizing his commitment to enhancing medical technology through effective commercialization strategies.123